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Abstract 
Rationale: Maternal obesity pre-programmes offspring to develop obesity and associated 
cardiovascular disease. Perivascular adipose tissue (PVAT) exerts an anti-contractile effect on the 
vasculature, which is reduced in hypertension and obesity. 
Objective: To determine whether maternal obesity pre-programmes offspring to develop PVAT 
dysfunction in later life. 
Methods:  Female Sprague-Dawley rats were fed a diet containing 10% (control) or 45% fat (HFD) 
for 12 weeks prior to mating and during pregnancy and lactation. Male offspring were killed at 12 or 
24 weeks of age and tension in PVAT-intact or -denuded mesenteric artery segments measured 
isometrically. Concentration-response curves were constructed to U46619 and norepinephrine. 
Results: Only 24 week old HFD offspring were hypertensive (p<0.0001), although the anti-
contractile effect of PVAT was lost in vessels from HFD offspring of each age. Inhibition of nitric 
oxide (NO) synthase with 100 µM L-NMMA attenuated the anti-contractile effect of PVAT and 
increased contractility of PVAT-denuded arteries (p<0.05, p<0.0001). The increase in contraction was 
smaller in PVAT-intact than PVAT-denuded vessels from 12 week old HFD offspring, suggesting 
decreased PVAT-derived NO and release of a contractile factor (p<0.07).  An additional, NO-
independent effect of PVAT was evident only in norepinephrine-contracted vessels.  Activation of 
AMP-activated kinase (with 10µM A769662) was anti-contractile in PVAT-denuded (p<0.0001) and 
–intact (p<0.01) vessels and was due solely to NO in controls; the AMPK effect was similar in HFD 
offspring vessels (p<0.001 and p<0.01, respectively) but was partially NO-independent.   
Conclusions: The diminished anti-contractile effects of PVAT in offspring of HFD dams are 
primarily due to release of a PVAT-derived contractile factor and reduced NO bioavailability.  
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Introduction 
Obesity is a major health problem worldwide in both adults and children. Alarmingly, 42 million 
children under the age of five are either overweight or obese(1). Maternal obesity can influence 
offspring health, the so-called ―fetal programming of disease‖(2-4). Human and animal studies have 
shown that offspring of obese mothers and dams fed high fat diet (HFD) during pregnancy develop 
obesity, glucose intolerance and cardiovascular dysfunction(4-8). However, the mechanism by which 
maternal obesity programs offspring to develop cardiometabolic disorders is currently unknown. 
Resistance artery dysfunction plays a major role in the progression of cardiovascular disease and 
obesity-related insulin resistance(9). Vascular contractility is regulated by the endothelium; in health, 
the endothelium releases both vasodilator and vasoconstrictor agents (primarily nitric oxide (NO) and 
endothelin-1, respectively); an imbalance in their actions due to endothelial dysfunction can lead to 
the development of hypertension(10). Several studies have demonstrated that if rats and mice are fed 
an obesogenic diet during pregnancy and lactation, then despite their weaning onto a standard rodent 
chow, the offspring also display endothelial dysfunction(4;11;12), suggesting that this too results from 
fetal programming.  Recently, perivascular adipose tissue (PVAT) has been recognised as an 
endocrine organ that secretes a number of bioactive proteins (adipokines; reviewed by(13) which can 
modulate vascular tone(14). PVAT exerts an anti-contractile effect in healthy subjects through the 
release of PVAT-derived relaxant factors(15). Animal studies have demonstrated PVAT-induced 
vasodilation in numerous vascular beds(15-19) and have identified several vasorelaxant factors, 
including adiponectin and NO(20). However, obesity results in oxidative stress, hypoxia and 
inflammation of the adipose tissue leading to abnormal adipokine production(21). Animal studies 
have linked an increased PVAT mass with diminished anti-contractile effect(22-24). In rat mesenteric 
arteries, this is associated with reduced of adiponectin, increased reactive oxygen species formation, 
macrophage infiltration into PVAT and reduced NO bioavailability(23). However, the effect of 
maternal obesity on PVAT regulation of resistance artery tone in offspring is currently unknown. 
AMP-activated protein kinase (AMPK) maintains energy homeostasis(25) and plays a key role in 
glucose, lipid and protein metabolism(26). These processes are dysregulated in obesity and metabolic 
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disorders, conditions in which AMPK activity is also reduced(27).  Thus, an impaired AMPK 
pathway may be a contributory factor to endothelial dysfunction in obese rats. Moreover, endothelial 
dysfunction in obese rats is alleviated by AMPK activation which increases phosphorylation (and thus 
activation) of endothelial nitric oxide synthase (eNOS)(28). Weston et al.(29) concluded that AMPK 
plays a role downstream of adiponectin receptor activation in PVAT-dependent hyperpolarisation of 
myocytes, thus reduced AMPK activation could also modify the PVAT effect on vascular contractility 
in offspring. 
We hypothesised that fetal programming, induced by maternal obesity, would cause vascular changes 
in offspring which resulted not only from endothelial dysfunction but also from PVAT dysfunction.  
Thus the aim of the present study was to identify any such changes in endothelial or PVAT control of 
vascular tone with particular focus on the involvement of NO and AMPK. 
Methods 
Animals 
All animal procedures complied with the United Kingdom Animals (Scientific Procedures) Act 1986.  
Animals were housed under a 12 h light/12 h dark cycle and provided with food and water ad libitum. 
Female Sprague Dawley (SD) rats (185-200g, Charles River, UK) were fed an obesogenic, 45% fat 
diet (824018, SDS Diets, Witham, UK) (HFD) or a control 10% fat diet (824050, SDS diets) for a 12-
week period. Rats were then mated and continued on their respective diets during pregnancy and 
lactation. At weaning, male offspring were provided with 10 % fat diet (824050, SDS diets) until 
sacrifice at either 12 or 24 weeks of age. Body weight was recorded fortnightly in the dams and 
weekly in the offspring. 12/24 week old offspring of control dams (12/24wCO), 12/24 week old 
offspring of HFD dams (12/24wHFDO).  
Blood pressure 
Systolic and diastolic blood pressure were measured in conscious rats using a CODA tail cuff blood 
pressure monitoring system(30) (Kent Scientific, Torrington, CT, USA).  
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Blood glucose measurement 
Fasting blood samples were taken from the lateral tail vein of conscious rats for determination of 
plasma insulin levels (Rat Insulin ELISA, Alpco, Salem, NH, USA) and blood glucose concentration 
(automatic blood glucose monitor, Contour, Bayer Consumer Care AG, Basel, Switzerland). 
Adipocyte size measurement  
PVAT adipocyte sizes were determined as described previously(31). 
Wire myography  
Animals were fasted overnight and killed by CO2 inhalation followed by mechanical disruption of the 
diaphragm. On the experimental day epididymal fat pads were weighed. The mesenteric vascular bed 
was isolated and placed in ice-cold physiological salt solution (PSS). Second order mesenteric arteries 
with surrounding PVAT (+PVAT) or cleaned of all fat and connective tissue (-PVAT) were mounted 
on 40 µm wires in a small vessel wire myograph and equilibrated in PSS at 37
o
C (gassed with 95% air 
and 5% CO2) for 30 min. Vessels were then normalised using a standardised technique(32) and again 
equilibrated for 30 minutes. Chart 5 Pro Software (ADInstruments, Oxford, UK) was used to record 
and measure changes in the vessel tension.  
Pharmacological modulation 
Cumulative concentration-response curves to U46619 (9,11-Dideoxy-9a,11a-methanoepoxy 
prostaglandin F2a, R&D Systems, Abingdon, UK) and norepinephrine bitartrate (Sigma-Aldrich, 
Gillingham, UK) were constructed (10nmol/L-3µmol/L and 1nmol/L-30µmol/L respectively). Where 
appropriate, arteries were incubated with the AMPK activator - A769662 (6,7-dihydro-4-hydroxy-3-
(2'-hydroxy[1,1'-biphenyl]-4-yl)-6-oxo-thieno[2,3-b]pyridine-5—carbonitrile, 10µM, R&D Systems) 
for an hour and/or NOS inhibitor - L-NMMA acetate (N
G
-monomethyl-L-arginine, 100µM, , R&D 
Systems) for 45min. Functional endothelial integrity was assessed by relaxation to acetylcholine 
(10µM, Sigma- Aldrich) in arteries pre-contracted with U46619. 
©    2016 Macmillan Publishers Limited. All rights reserved.
5 
 
Tissue lysates 
PVAT-denuded arteries and PVAT were snap-frozen in liquid nitrogen and stored at -80
o
C. Tissue 
lysates were then prepared with RIPA buffer (Sigma-Aldrich) supplemented with protein protease 
inhibitors (Roche, Mannheim, Germany) and phosphatase inhibitors (Roche) using a glass:glass 
homogeniser, rotated at 4
o
C for 30 min and then centrifuged (21,910 x g, 5 min, 4
o
C). Protein 
concentration was measured using a Bradford assay(33). The supernatants were divided into aliquots 
and stored at -80
o
C. On the experimental day one volume of sample buffer (320mM Tris, 5% SDS, 
25% glycerol, 5% β-mercaptoethanol, 1% bromophenol blue) was added to four volumes of the tissue 
lysates. 
Western blot  
Equal amounts of proteins (40µg) were separated by stain-free SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE, 7.5%), and then transferred to mini low fluorescence PVDF membranes 
(Bio-Rad Laboratories, Hemel Hempstead, UK). The blots were visualised using Chemidoc MP 
Imaging system (Bio-Rad Laboratories), then the membrane was blocked with 3.5 % (w/v) BSA in 
TBS-T (10mM Tris pH8, 150mM NaCl, 0.1% Tween 2.0) for an hour at room temperature (RT) 
before exposure to primary antibody (anti-eNOS 1:200 Santa Cruz Biotechnology, Dallas, TX, USA; 
anti-peNOS
ser1177
 1:200 Santa Cruz Biotechnology;  anti-AMPKα 1:500 Cell Signalling; anti-
pAMPKα 1:500 Cell Signalling; 4oC, overnight) then horseradish peroxidase-conjugated secondary 
antibody (goat anti-rabbit, 1:10000 Jackson ImmunoResearch Laboratories, West Grove, PA, USA) 
for an hour at RT. Chemiluminescence was performed with Clarity Western ECL Substrate (Bio-Rad 
Laboratories) and detected using Chemidoc MP Imaging system. Blots were quantified using 
ImageLab 5.2.1. (Bio-Rad Laboratories) software and protein expression was normalised to the total 
protein of the sample as previously described by(34).  
Data analysis 
If the standardized differences between groups are similar to those in our previous studies, we 
anticipated samples sizes of 8-10 would be sufficient to demonstrate significant differences in each 
experimental protocol with a power of 90% at a 5% level of confidence. 
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Data are presented as mean ± S.E.M unless otherwise stated. Data were expressed as percentage 
contraction to 60mM KPSS for U46619 dose responses and curves were fitted using non-linear 
regression analysis.  
Statistical analysis for the wire myograph experiments was performed using GraphPad Prism (v6, 
GraphPad software, La Jolla, CA, USA) with repeated measures two-way ANOVA test followed by 
Bonferroni post hoc test for multiple comparisons. Cardio-metabolic parameters were analysed using 
GraphPad Prism (v6, GraphPad software) with an unpaired t test, whereas protein expression was 
analysed using one-sample t-test. Researchers were not blinded to animal grouping. 
 
Results 
Maternal characteristics 
At the time of mating, body weight, insulin, systolic and diastolic blood pressure were all significantly 
increased in HFD females compared to controls although glucose remained unchanged (Figure 1). All 
six control rats had uncomplicated pregnancies whereas only eight out of fifteen rats fed a high fat 
diet successfully mated and two of these died as a result of pregnancy-related complications.  There 
was no difference in litter sizes between the six control (median 15 pups/dam, range 14-17) and six 
HFD (median 15 pups/dam, range 13-15) dams. 
Offspring characteristics: 
Body weight of HFD offspring was similar to that of controls at 12 weeks of age (12wHFDO) but was 
significantly increased at 24 weeks (24wHFDO) (p<0.0001, n=21-23, Figure 2a) and adipocytes were 
significantly larger in HFDO of both ages (each p<0.0001, n=10, Figure 2b). Nevertheless, 
epididymal fat pad weights were increased in both 12wHFDO (p<0.01, n =21-23) and 24wHFDO 
(p<0.001, n=14-23) (Figure 2c) and the plasma insulin concentration was also increased in both 
12wHFDO (p<0.01, n=8-16) and 24wHFDO (p<0.05, n=10-13, Figure 2d). Both systolic and 
diastolic blood pressure remained unchanged between the two groups at the 12 weeks of age. 
However, systolic blood pressure was elevated from week 16 onwards in the HFDO and both systolic 
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and diastolic blood pressure was also increased in 24wHFDO (p<0.0001, n=8-12, Figure 2e). In 
comparison to age-matched controls, U46619-contracted mesenteric arteries from 24wHFDO rats 
relaxed less to 10 µM acetylcholine (p<0.05, n=8, Figure 2f), although this was not evident in vessels 
from 12wHFDO.   
The anti-contractile effect of PVAT is lost in offspring of HFD dams 
The constriction to KPSS (60 mM K
+
) was similar in PVAT-denuded and PVAT–intact vessels from 
12wCO and 12wHFDO as well as 24wCO and 24wHFDO (all n=8, Figure 3a,b).   
The presence of PVAT reduced contractions to U46619 in vessels from control offspring at both 12 
(Figure 3c) and 24 (Figure 3e) weeks of age (p<0.001 and p<0.05 respectively, n=8). This effect was 
lost in both 12wHFDO and 24wHFDO (Figures 3d,f). When vessels were contracted with 
norepinephrine, the effect of PVAT was evident in 12wCO and 24wCO arteries and also in 
12wHFDO arteries but was totally lacking in 24wHFDO vessels (Supplementary figure 1).  
Nitric oxide contributes to the anti-contractile effect of PVAT in offspring of control dams. 
Inhibition of NOS with L-NMMA (100µM) increased contractility to U46619 in both PVAT-denuded 
(Figure 4a) and PVAT-intact (Figure 4c) arteries from 12wCO (each p<0.0001, n=8). Moreover, 
PVAT was still able to exert an anti-contractile effect against norepinephrine following NOS 
inhibition in 12wCO and 12wHFDO arteries (Supplementary figure 2).   
NOS inhibition led to a similar increase in contractility to U46619 in PVAT-denuded control and 
12wHFDO vessels (Figures 4a,b). However, when PVAT was present, the increase in the U46619-
induced (3µmol/L) constriction following incubation with L-NMMA (5.7 ± 16.1%, n=8) was smaller 
in the 12wHFDO vessels than in the controls (38.6 ± 7.5%, n=8; p<0.05, Figures 4c,d,). Although 
eNOS expression was, in fact, increased in PVAT from 12wHFDO compared to controls (p<0.01, 
n=4, Supplementary Figure 4). There was a trend towards reduced peNOS expression compared to 
controls but this did not achieve statistical significance (p=0.31, n=4, Supplementary Figure 4). There 
was no significant difference in eNOS and peNOS expression in mesenteric arteries from 12 week old 
offspring after PVAT removal (Supplementary Figure 4). 
©    2016 Macmillan Publishers Limited. All rights reserved.
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Inhibition of NOS increased contractility of PVAT-denuded vessels from both 24wCO and 
24wHFDO but was more pronounced in the latter (Figures 5a,b, Supplementary Figure 3). This effect 
was also observed when 24wCO and 24HFDO arteries were constricted with norepinephrine 
(Supplementary figure 5). In the presence of PVAT, contractions to U46619 were similar in control 
and HFD vessels following NOS inhibition with L-NMMA (Figures 5c,d). The proportion of eNOS 
which was phosphorylated was not significantly different in PVAT-denuded arteries but it was 
decreased in PVAT (Supplementary figure 6) from 24wHFDO compared to their respective controls. 
The relative expression of eNOS was decreased in PVAT but it was increased in PVAT-denuded 
arteries from 24wHFDO compared to their respective controls (Supplementary figure 6).   
AMPK activation reduces vascular contractility.  
AMPK activation with A769662 reduced the contractile response to U46619 in PVAT-denuded 
mesenteric artery segments from both 12wCO (p<0.0001, n=8, Figure 6a) and 12wHFDO (p<0.001, 
n=8, Figure 6b).  Although, the anti-contractile effect of the AMPK activator was lost following 
inhibition of NOS in 12wCO vessels constricted with U46619 (Figure 6a), it was still present in 
12wHFDO (p<0.05, n=8, Figure 6b). AMPK also reduced contractions to U46619 in PVAT-intact 
vessels from both 12wCO and 12wHFDO (p<0.01, n=8, Figures 6c, 6d). NOS inhibition prevented 
the anti-contractile effects both of AMPK and of PVAT against tone induced by U46619 in 12wCO 
and 12wHFDO (Figures 6c,d). AMPK activation also led to a reduction in contractility of PVAT-
denuded and PVAT-intact vessels, constricted with noradrenaline from 12wCO and 12wHFDO  
(Supplementary figure 7). However, in the presence of the NOS inhibitor, AMPK was no longer able 
to relax vessels constricted with norepinephrine (Supplementary figure 7).  
AMPK activation reduced the contractile response to U46619 in PVAT-denuded arteries from both 
24wCO (Figure 6e) and 24wHFDO (Figure 6f) (p<0.0001, p<0.01 respectively, n=8); the anti-
contractile effect was lost in the presence of NOS inhibitor (Figures 6e,f). AMPK activation also 
induced vasorelaxation in PVAT-intact vessels from both 24wCO and 24wHFDO (p<0.0001 and 
p<0.01, respectively, n=8, Figures 6g,h).  AMPK activation was no longer effective in PVAT-intact 
arteries from both 24wCO and 24wHDFO incubated with the NOS inhibitor (Figures 6g,h). The 
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vasorelaxant effect of AMPK was also observed in PVAT-intact and PVAT-denuded vessels, 
constricted with norepinephrine, from 24wCO and 24wHFDO (Supplementary figure 8). 
The relative expressions of AMPK and phosphorylated AMPK (pAMPK) were increased in PVAT 
from 12wHFDO compared to their respective controls (Supplementary figure 9). There was no 
difference in AMPK and pAMPK expression in PVAT from 24wHFDO compared to their respective 
controls (Supplementary figure 9). 
Discussion 
This study investigated the effect of a maternal high fat diet on PVAT regulation of resistance artery 
tone in offspring. The novel finding of this study was that the anti-contractile effect of PVAT was lost 
in offspring of HFD dams at both 12 and 24 weeks of age. The lost anti-contractile properties of 
PVAT could be due in part to a reduction in PVAT-derived NO bioavailability but also to the 
presence of an unidentified contractile factor in 12wHFDO. However, at 24 weeks of age both 
vascular and PVAT-derived NO are altered in HFDO. Vascular NO was increased in 24wHFDO, 
whereas PVAT-derived NO appeared to be reduced. There was no difference in AMPK-induced 
modulation of vascular tone between CO and HFDO at both ages. The loss of the PVAT effect in 
12wHFDO was particularly interesting since it occurred prior to any measurable change in blood 
pressure.  
Obesity has detrimental effects on health; it can lead to the development of insulin resistance, the 
metabolic syndrome, type 2 diabetes mellitus and increased blood pressure; all are major risk factors 
for cardiovascular disease(35). Maternal obesity can be effectively induced in various rodents by high 
fat or high sucrose feeding(36), however it can lead to infertility and pregnancy-related 
complications(4;37;38). This was evident in the present study in which all six control rats had 
uncomplicated pregnancies whereas only eight out of fifteen rats fed the HFD successfully mated, 
with two dying near term as a result of pregnancy-related complications (triggered by in utero deaths). 
The high fat diet resulted in a significantly increased body weight, both before and during pregnancy, 
compared to controls and an increase in plasma insulin levels, suggesting that these rats had 
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developed insulin resistance. Dams fed the high fat diet also displayed an increased systolic and 
diastolic blood pressure as typically seen in human obesity(39). 
The maternal environment can also influence the offspring’s long-term health, so-called ―fetal 
programming of disease‖. Numerous studies have shown that maternal obesity increases the 
offspring’s adiposity and has negative effects on cardio-metabolic health (reviewed in(40)). In the 
present study, blood pressure and body weight were similar in 12wCO and 12wHFDO. However, 
systolic blood pressure was elevated from week 16 onwards in the HFDO and progressively 
increased with age. Diastolic blood pressure was also significantly increased in 24wHFDO. This is 
consistent with previous studies, which also found that the cardio-metabolic status of offspring of 
obese dams changes at 24 weeks of age (increased body weight and blood pressure)(4;41;42).  
Despite weaning onto standard chow diet (10% fat) adiposity and insulin levels were increased in 
HFDO at both 12 and 24 weeks of age, again consistent with previous findings(4). Thus, in the 
present study, the offspring of the high fat diet dams demonstrated clear evidence of pre-programmed 
cardio-metabolic dysfunction. 
PVAT exerts anti-contractile effects on vessels in healthy subjects through the release of PVAT-
derived relaxant factors(17;24) but this anti-contractile effect is reduced in hypertension(43;44) and 
obesity(15). Therefore, the present study hypothesised that maternal obesity might pre-programme 
offspring not only to develop endothelial dysfunction as previously described(4) but also PVAT 
dysfunction later on in life. 
Our study showed that PVAT reduced contractions to U46619 and to norepinephrine in mesenteric 
arteries isolated from 12wCO and 24wCO rats and that maternal diet could influence PVAT function 
in offspring.  Thus, the anti-contractile effect of PVAT was lost in 24wHFDO arteries constricted with 
norepinephrine and was abolished in mesenteric arteries from 12wHFDO and 24wHFDO contracted 
with U46619.  Nevertheless, after NOS inhibition there was still clear evidence for an anti-contractile 
effect of PVAT when HFDO vessels were contracted with norepinephrine, suggesting that 
norepinephrine, but not U46619, stimulated the release of an additional PVAT-derived vasorelaxant 
factor. Over-nutrition during either pregnancy or lactation alone is able to pre-programme 
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hypertension in offspring(42). Therefore, in the present study, the observed changes in offspring 
PVAT effects could be a result of pre-programming in utero or be due to over-nutrition during 
lactation. 
The anti-contractile properties of PVAT were lost in 12wHFDO in which plasma insulin levels were 
increased but the rats were not overweight. The endothelial function was also preserved in 12wHFDO 
but was reduced in 24wHFDO vessels compared to controls. Thus, metabolic and PVAT dysfunction 
preceded obesity, endothelial dysfunction and hypertension in HFDO. In 24wHFDO endothelial and 
PVAT dysfunctions were against a background of obesity and hypertension. Nevertheless, PVAT 
dysfunction may contribute to the progression of cardio-metabolic disorders as it occurs prior to 
obesity and hypertension in HFDO.  
PVAT induces an anti-contractile effect through the release of NO(20). In the present study, NOS 
inhibition with L-NMMA caused a greater increase in U46619-induced contractions in the presence 
than in the absence of PVAT in both 12wCO and 24wCO. This suggests that the anti-contractile effect 
of PVAT in control offspring is NO-dependent at both ages, consistent with the reported role of 
PVAT-derived NO in mouse mesenteric arteries(20). The detection of eNOS and peNOS expression 
in PVAT provided further support in favour of PVAT as a source of NO. However, although protein 
expression of eNOS was maintained in arteries from 12wHFDO, following incubation with L-NMMA 
the increase in contraction was lower in the PVAT-intact arteries from 12wHFDO compared to those 
from 12wCO. These data indicate a possible reduction in the PVAT-derived NO bioavailability could 
be responsible for the loss of anti-contractile effect of PVAT in 12wHFDOs. However, PVAT was 
still able to exert an anti-contractile effect to norepinephrine when 12wCO and 12wHFDO vessels 
were incubated with the NOS inhibitor. This suggests that NO is not the sole factor responsible for 
mediating the anti-contractile effect of PVAT to norepinephrine in vessels from 12-week-old 
offspring. Adiponectin might be the additional vasorelaxant factor as it is a downstream effector of β3-
adrenoceptor activation(29) and the anti-contractile effect of PVAT in lost in mice following 
adiponectin gene deletion(20).  
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Although contractions to U46619 were similar in 24wCO and 24wHFDO PVAT-denuded vessels, 
they were significantly enhanced in 24wHFDO vessels after incubation with L-NMMA. This suggests 
an increased basal release of NO which must compensate either for loss of other endothelium-derived 
vasodilator factors or for an increased contractile effect of the endothelium in the 24wHFDO vessel 
(possibly due to enhanced release of contractile prostanoids; examination of this was beyond the 
scope of the present study). Unlike in the -PVAT vessels, there was no difference in response to 
U46619 in PVAT-intact vessels after NOS inhibition.  Nevertheless, it was noticeable that in the 
presence of PVAT the 24wCO and 24wHFDO vessel responses to U46619 were similar to those of -
PVAT vessels from 24wHFDO and that in all three the responses were greater than those in -PVAT 
24wCO. This may be an indication that the release of NO, which normally counter-balances the 
effects of a PVAT-derived contractile factor (both in control and HFD offspring vessels) is increased 
in the 24wHFDO vessels to offset an increased release of the unidentified contractile factor.  It was 
therefore expected that expression of eNOS in the endothelium might be enhanced to account for the 
increased NO.  Indeed, in comparison to controls, eNOS expression was increased in PVAT-denuded 
or -intact mesenteric arteries from 24wHFDO, but the total expression of phosphorylated (active) 
eNOS was unchanged (with a trend towards a reduction).   Thus, some other factor, such as reduced 
NO degradation, must be responsible for the elevation of NO. 
Obesity leads to impaired release of constricting and dilating factors from both endothelium and 
PVAT(46;47). In the present study, there was no evidence of endothelium dysfunction in the HFDO 
although there was a lack of anti-contractile effect of mesenteric artery PVAT in the 24wHFDO 
which could be partially due to the release of an unidentified contractile factor from the artery 
together with reduced PVAT-derived NO bioavailability.  
AMPK phosphorylates eNOS at ser1177, which leads to eNOS activation and increased NO 
bioavailability which then reduces vascular tone(48;49). Activation of AMPK can also induce 
vasorelaxation through stimulation of myocyte sarcoendoplasmic reticulum  calcium transport 
ATPase (SERCA) and large conductance calcium activated potassium channels (BKCa) 
channel activity which each result in a lowering of intracellular calcium(29;50).  The active 
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(phosphorylated) form of AMPK was shown to be reduced in the skeletal muscle and heart of fetuses 
from sheep fed a high fat diet during pregnancy(51;52). Therefore, in the present study, the effect of 
AMPK activation on the vascular contractility in offspring was also investigated. AMPK activation 
with A769662 resulted in a reduction in vessel contractility to both U46619 and norepinephrine that 
was partially NO-mediated in 12wCO and 24wCO and thus AMPK could contribute to the anti-
contractile effect of PVAT by increasing NO release from the PVAT. In PVAT-denuded vessels from 
12wHFDO the AMPK activator was still able to induce the vasorelaxation against both U46619 and 
norepinephrine contractions in the presence of L-NMMA. This NO-independent relaxant effect of 
A769662 was possibly due to a direct effect on the vascular smooth muscle.  Although AMPK 
activity is reduced in heart and skeletal muscle of sheep fetuses when the mother is fed a high fat diet 
during pregnancy(51;52), in the present study AMPK expression and phosphorylated AMPK 
expression were increased in PVAT from 12wHFDO compared to their respective controls. This 
could account for the preserved AMPK-induced modulation of vascular tone in HFDO. AMPK also 
exerted a partially NO-dependent vasorelaxation of PVAT-intact and PVAT-denuded mesenteric 
arteries from 24wHFDO, constricted with either U46619 or norepinephrine. Thus, it appears that 
maternal obesity does not affect the ability of AMPK to induce vasorelaxation in offspring mesenteric 
arteries even when PVAT is dysfunctional.  
The current study has clearly demonstrated that maternal obesity in rats adversely affects vascular 
responses in offspring as young as 12 weeks old by reducing the anti-contractile effect of PVAT. The 
subsequent enhanced contractility to U46619 was in part due to enhanced release of an unidentified 
contractile factor but also due partially to loss of NO. Nevertheless, the AMPK signalling was intact 
in the obese dam offspring. Thus, AMPK activators, such as metformin (which upregulates eNOS 
phosphorylation and increases NO bioavailability in the vasculature,(53)), may be therapeutically 
useful for maintaining PVAT function and opposing the development of pre-programmed 
hypertension. Importantly, translating these data to the human situation suggests that maternal obesity 
may already have pre-programmed the development of hypertension in young adults, highlighting the 
©    2016 Macmillan Publishers Limited. All rights reserved.
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importance of educating young children of obese mothers about lifestyle changes and/or the use of 
treatments to minimise the consequence of the perinatal damage that has already occurred. 
Supplementary information is available at International Journal of Obesity’s website.  
©    2016 Macmillan Publishers Limited. All rights reserved.
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Figure 1. Cardio-metabolic profile of dams. Body weight (A), serum insulin (B) and blood pressure 
(C) were increased in HFD (grey bars) dams compared to controls (black bars) prior to pregnancy but 
the serum glucose concentration (D) was similar. Data are expressed as mean±SEM, n=6, * p<0.05, 
** p<0.01, **** p<0.0001, unpaired t-test. 
Figure 2. Cardio-metabolic characteristics of offspring. Body weight (A) was increased in 24 week 
old offspring of HFD dams (HFDO). Adipocytes (B) were larger in both 12 and 24 weeks old offspring 
of HFD dams. Epididymal fat pads (C) and insulin (D) were increased in 12 and 24 week old offspring 
of HFD dams compared to their respective controls (CO). Systolic blood pressure (E) was significantly 
increased from week 16 onwards in offspring of HFD dams, whereas diastolic blood pressure (E) was 
significantly increased in 24 week old offspring of HFD dams.  U46619 pre-constricted arteries from 
24 week old offspring of HFD dams relaxed less to 10 µM acetylcholine compared to control vessels 
(F) but this was not evident in vessels from 12 week old offspring of HFD dams. Data are expressed 
as mean±SEM, n=12-23, * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001, unpaired t-test/two-way 
ANOVA with Bonferroni post hoc test.  
Figure 3. The anti-contractile effect of PVAT is lost in offspring of HFD dams. The contractions to 
KPSS (60 mM K+) were similar in PVAT-denuded and PVAT-intact vessels from (A) 12 and (B) 24 week 
old offspring. PVAT reduced contractions to U46619 in vessels from 12 (C) and 24 (E) week old 
offspring of control dams but not in arteries from 12 (D) and 24 (F) week old offspring of HFD dams. 
Data are expressed as mean±SEM, n=8, * p<0.05, *** p<0.001, one-way/two-way ANOVA.   
Figure 4. Nitric oxide contributes to the anti-contractile effect of PVAT. NOS inhibition with L-
NMMA increased contractions to U46619 in arteries with and without PVAT from 12 week old 
offspring of control (A,C) and HFD (B,D) dams, which abolished the anti-contractile effect of PVAT. 
Data are expressed as mean±SEM, n=8, * p<0.05, ** p<0.01, **** p<0.0001, two-way ANOVA. 
Fig. 5 Nitric oxide synthase inhibition increases contractions in 24 week old offspring of HFD dams. 
NOS inhibition with 100µM L-NMMA increased contractions to U46619 in PVAT-denuded vessels 
from 24 week old offspring of control (A) and HFD (B) dams but was more pronounced in the latter. 
It also lead to an increase in contractions in PVAT-intact mesenteric arteries isolated from 24 week 
old offspring of control (C) and HFD (D) dams, which abolished the anti-contractile effect of PVAT. 
Data are expressed as mean±SEM, n=8, * p<0.05, **** p<0.0001, two-way ANOVA. 
Figure 6. AMPK reduces vascular contraction in NO-dependent manner in control offspring. AMPK 
activation with 10 µM A769662 (A76) reduced vascular contractions to U46619 in arteries without 
PVAT from 12 and 24 week old offspring of control (A) and HFD (B) dams; this was abolished in the 
presence of NOS inhibitor (100 µM, L-NMMA) in the control (A) but not in HFD (B) vessels.  AMPK 
activation also reduced contractions to U46619 in PVAT-intact arteries from control (C) and HFD (D) 
vessels whereas in the presence of L-NMMA it lead to a large increase in contraction in offspring of 
control (C) but not in offspring of HFD (D) dams. A76 also reduced vascular contractions to U46619 in 
arteries without (A,B) and with (C,D) PVAT from 24 week old offspring of control (E,G) and HFD (F,H) 
dams in a NO-dependent manner. Data are expressed as mean±SEM, n=8, * p<0.05, ** p<0.01, *** 
p<0.001, **** p<0.0001, two-way ANOVA.  
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